Latest news
French Ferments du Futur Secures €20M for Second Research Phase Under France 2030 - Cultivated XCultivated X · Tue, 04 Aug 2026 14:12:47 GMTEstrella Immunopharma Activates Baylor Scott & White Research Institute as Second Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT